COVID-19 vaccines were found to cut the risk of heart failure by up to 55% and blood clots by up to 78% following COVID infection, according to a new study published in the British Medical Journal.
The positive health effects lasted for up to a year and were more pronounced right after getting vaccinated.
Denise Fractious, 68, of Pasadena, receives her COVID vaccine during a flu and COVID-19 vaccination clinic at Kaiser Permanente Pasadena on Oct. 12, 2023, in Pasadena, Calif.
Francine Orr/Los Angeles Times via Getty Images, FILE
Researchers looked at over 20 million people in Europe; half of them were vaccinated against the virus, and half were not. Vaccines included in the research were Moderna, Pfizer, AstraZeneca and Johnson & Johnson.
During the period of study, researchers looked at the original strain of the virus and the Delta variant.
COVID vaccines reduced the risk of blood clots in the veins by 78% within a month of obtaining the dose, according to the researchers’ findings. It also reduced the risk of blood clots in the arteries by 47% and heart failure by 55%, the study found.
In this Feb. 8, 2022, file photo, a Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site.
Rogelio V. Solis/AP, FILE
Researchers said COVID vaccines reduced the risk of a blood clot in the vein by 47%, a blood clot in an artery by 28% and heart failure by 39% in the six-month period after vaccination.
Adults over the age of 65 are now able to get an additional updated COVID-19 vaccine to protect against severe hospitalization and death, according to the U.S. Centers for Disease Control and Prevention.